Nicolas Delanoy

Statistics

Publications

Citations

599

H-Index

Active since

2014

Affiliations

Hôpital Européen Georges-Pompidou(Current)

Institut Gustave Roussy

Assistance Publique – Hôpitaux de Paris

Centre Léon Bérard

Sorbonne Université

Nicolas Delanoy is an author at Hôpital Européen Georges-Pompidou specializing in medicine, oncology, and metastatic castration-resistant prostate cancer.

ORCID

Publications per year

2014–2023

Publications

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study

Nicolas Delanoy, Jean‐Marie Michot, Thibault Comont et al. · The Lancet Haematology · 2018 · 292 citations

Pharmacy, Hematology, Immunology +16

Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer

Antoine Angelergues, Denis Maillet, Aude Fléchon et al. · European Journal of Cancer · 2014 · 53 citations

Medicine, Oncology, Pharmacology +16

Sequencing of Taxanes and New Androgen-targeted Therapies in Metastatic Castration-resistant Prostate Cancer: Results of the International Multicentre Retrospective CATS Database

Nicolas Delanoy, Anne-Claire Hardy-Bessard, Eleni Efstathiou et al. · European Urology Oncology · 2018 · 31 citations

Medicine, Oncology, Urology +16

Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial

Gwénaël Ferron, Gaëtan De Rauglaudre, Stéphanie Bécourt et al. · Gynecologic Oncology · 2023 · 27 citations

Medicine, Gynecology, Oncology +14

The impact of the Paris terrorist attacks on the mental health of resident physicians

Jules Grégory, Jean de Lépinau, Ariane de Buyer et al. · BMC Psychiatry · 2019 · 25 citations · Full text

Medicine, Emergency Medicine, Psychiatry +12

1–5 of 14